About Monarch Bioimplants
Monarch Bioimplants is a company based in Root (Switzerland) founded in 2016 by Thomas Freier. Monarch Bioimplants has raised $24.93 million across 2 funding rounds from investors including FastTrack Ventures and Global Emerging Markets. Monarch Bioimplants operates in a competitive market with competitors including Avation, BioCircuit, Epineuron, Tulavi Nerve Therapeutics and Micro Leads, among others.
- Headquarter Root, Switzerland
- Founders Thomas Freier
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$24.93 M (USD)
in 2 rounds
-
Latest Funding Round
$23.41 M (USD), Series B
Sep 28, 2020
-
Investors
FastTrack Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Monarch Bioimplants
Monarch Bioimplants has successfully raised a total of $24.93M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $23.41 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Monarch Bioimplants
Monarch Bioimplants has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include FastTrack Ventures and Global Emerging Markets.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Investments in tech startups are managed by FastTrack Ventures.
|
Locked | Locked | Locked |
Investor details for Monarch Bioimplants
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Monarch Bioimplants
Investment portfolio details for Monarch Bioimplants
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Monarch Bioimplants
Detailed financials for Monarch Bioimplants
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Monarch Bioimplants Comparisons
Peer comparison for Monarch Bioimplants
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Monarch Bioimplants
Monarch Bioimplants operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, BioCircuit, Epineuron, Tulavi Nerve Therapeutics and Micro Leads, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| Locked | Locked | Locked |
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
|
|
| Locked | Locked | Locked |
Medical devices for peripheral nerve injury treatment are provided.
|
|
| Locked | Locked | Locked |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| Locked | Locked | Locked |
Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed.
|
|
| Locked | Locked | Locked |
Provides advanced laser therapy solutions for healthcare applications.
|
Detailed competitors of Monarch Bioimplants
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Monarch Bioimplants
Complete news archive for Monarch Bioimplants
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monarch Bioimplants
Monarch Bioimplants was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Monarch Bioimplants is headquartered in Root, Switzerland. It is registered at Root, Lucerne, Switzerland.
Monarch Bioimplants is a funded company, having raised a total of $24.93M across 2 funding rounds to date.
Developer of bioimplant for peripheral nerve repair. The company has a NeuroShield device that provides non-constricting protection for the nervous system. It is made of naturally occurring Chitosan which shields nerves from further damage and promotes faster regrowth.
Monarch Bioimplants's top competitors include Avation, Tulavi Nerve Therapeutics and Epineuron.
Monarch Bioimplants has 2 investors. Key investors include FastTrack Ventures, and Global Emerging Markets.